Abstract
Background Low hand grip strength (HGS) predicts several conditions, but its value outside of the older adult population is unclear. We sought to identify the most salient factors associated with HGS using a rich list of candidate variables while stratifying by age and sex.
Methods We used data from the initial visit from the Project Baseline Health Study (N=2502) which captured detailed demographic, occupational, social, lifestyle, and clinical data. We applied MI-LASSO using group methods to determine variables most associated with HGS out of 175 candidate variables. We performed analyses separately for sex and age (<65 vs. ≥65).
Results Race was associated with HGS to varying degrees across groups. Osteoporosis and osteopenia were negatively associated with HGS in female study participants. Immune cell counts were negatively associated with HGS for male participants ≥65 (neutrophils) and female participants (≥65, monocytes; <65, lymphocytes). Most findings were age and/or sex group-specific; few were common across all groups.
Conclusions Several of the variables associated with HGS in each group were novel, while others corroborate previous research. Our results support HGS as a useful indicator of a variety of clinical characteristics; however, its utility varies by age and sex.
Introduction
Hand grip strength (HGS) is a noninvasive and reliably measured biomarker that is most commonly assessed with a hydraulic hand dynamometer. Primarily studied in older adults, HGS affords a consistent indicator of overall strength. However, it is most informative when paired with a measure of lower extremity strength [1]. Lower HGS in older adults is associated with limitations in functional mobility and upper extremity activity [2-6]. Likewise, decreased HGS in this population is also a consistent indicator of disease status and mental health status. Lower HGS is associated with conditions such as prediabetes[7], diabetes (especially with neuropathy), and their clinical indicators (e.g., higher hemoglobin A1c; higher fasting blood glucose) [8-11]. It is also associated with multimorbidity [12-15], malnutrition [16-19], sleep impairment [20-23], and psychological conditions such as depression [24-29] and impaired cognition [30,31].
Among healthy adults, HGS is highest in their 20s, typically maintaining through their 40s and decreasing thereafter, with consistent differences between sexes [32-41]. Using age-appropriate reference values, some researchers have identified cut points intended to identify older individuals with sarcopenia or clinically relevant weakness, and to predict disease or mortality [42-47]. For example, older adults with HGS values below 16 kg for females or 26-27 kg for males, may meet diagnostic criteria for sarcopenia and/or frailty and would benefit from further clinical assessment [35,42,48]. These cut points are generalizable to Japan, North America, Europe, and Australia, but not to other regions [49].
HGS also predicts future injury, disease, and mortality in older adults [50]. It is a strong predictor of incident cardiovascular disease, with estimated risk increasing 21% for each 5-kg decrease in HGS [51], although it may not predict specific incident cardiovascular events [52]. However, an increased risk of cardiovascular mortality is associated with lower HGS [51,53,54], with one study finding HGS to be a stronger predictor than systolic blood pressure for cardiovascular mortality, and other disease-specific and all-cause mortality [55]. This additional prognostic value of lower HGS as a predictor of all-cause mortality has been reported across several cohort studies from various geographical regions [51,53,56-66]. Low HGS also predicts future function in care-seeking and non-care-seeking populations [67-74] as well as falls and osteoporotic fractures among older adults [75-82], with the latter likely being directly related to reported associations with physical strength, functional mobility, and bone mineral density.
Current evidence suggests HGS as a biomarker with potential value for screening, diagnosis, and determining prognosis for a wide array of conditions. However, its value as an indicator/predictor of outcomes has not been well studied outside of the older adult population. Studies have typically focused on investigating HGS alongside other variables as indicators/predictors of a specific outcome rather than comprehensively investigating clinical factors and conditions associated with HGS.
The Project Baseline Health Study (PBHS) is a prospective cohort study of U.S. adults that has collected a wide array of personal, behavioral, and clinical characteristics that together comprise data sufficiently rich to allow deep phenotyping of study participants [83,84]. In this analysis, we examined participants in the BHS study cohort to identify the most salient factors associated with HGS by examining demographic, socioeconomic status-related health behaviors, medical conditions, symptoms, patient-reported outcomes, and laboratory measures across a wide adult age group while stratifying by age and sex to account for expected differences between these groups.
Results
Of the 2502 participants in the deeply phenotyped BHS cohort, 2366 (95%) completed baseline HGS assessment; 1318 (55.7%) were female and 1048 (44.3%) were male. In this cohort, 63.5% of participants identified as White (64.2% female; 62.6% male), 16.1% as Black (16.7%; 15.3%), 10.3% as Asian (8.3%; 12.8%), and 8.0% as Other (8.4%; 7.4%). The latter category included participants who identified as American Indian or Alaska Native, or Native Hawaiian or Other Pacific Islander, as well as those who indicated multiple racial identity backgrounds or provided a free-text response for race. Additionally, 11.4% of participants indicated Hispanic ethnicity (12.5%; 9.9%).
The 25th, 75th percentiles of HGS were 25 kg and 32 kg for female participants and 37 kg and 50 kg for male participants, respectively. Table 1 and Table 2 describe associations between HGS and demographic data according to sex. Younger age was significantly associated with higher HGS in both male and female participants. A plurality (41.8%) of the cohort attended study visits in Palo Alto, CA, while 21.6% were from Kannapolis, NC; 19.7% were from Durham, NC and 16.9% were from Los Angeles, CA. Of the 1375 female participants included after imputation, 300 (21.8%) were ≥65 years of age; 282 (25%) male participants (n=1127) were ≥65 years of age.
Summary of demographic characteristics for female study participants across hand grip strength classifications. P values calculated using Spearman correlation or Cochran-Armitage tests.
Summary of demographic characteristics for male study participants across hand grip strength classifications. P values calculated using Spearman correlation or Cochran-Armitage tests.
An association between Black race and higher HGS was seen in all female participants, regardless of age (Figure 1a and Figure 1b). In regression models using variables selected from the MI-LASSO, (Table 3) Black race was associated with approximately 3-4 kg higher HGS in female participants regardless of age group. No other variables identified by MI-LASSO were shared between female age groups. Among female participants, we identified several variables associated with HGS that were specific to age group. Of those identified, the categorical variables associated with ≥2 kg lower HGS among younger female participants were history of breast cancer, osteopenia, and transient ischemic attack (TIA). Continuous variables where higher values were associated with lower HGS in younger female participants included estimated glomerular filtration rate (eGFR), World Health Organization (WHO) Disability Assessment Schedule (WHODAS 2.0) total score, and cigarette pack-years smoked. Among older female participants, additional categorical variables associated with ≥2 kg lower HGS were body image concerns and monocyte count. Continuous variables where higher values were associated with lower HGS in this group included low-density-lipoprotein (LDL) cholesterol, Generalized Anxiety Disorder-7 (GAD-7) score, and absolute monocyte count.
Characteristics associated with hand grip strength after LASSO regression using multiply imputed data: females study participants aged <65 years (N=1075). Abbreviations: WHODAS, World Health Organization Disability Assessment Schedule 2.0; HbA1c, hemoglobin A1c; eGFR, estimated glomerular filtration rate.
Characteristics Associated with hand grip strength after LASSO regression using multiply imputed data: females study participants ≥65 years (N=300). Because no study participants in this age/sex group had type 1 diabetes mellitus, this variable was removed from the model for this group. Abbreviations: GAD-7, Generalized Anxiety Disorder; LDL, low density lipoprotein; PANAS, Positive and Negative Affect Schedule.
Characteristics associated with hand grip strength after LASSO regression using multiply imputed data: male study participants aged <65 years (N=845). Abbreviations: ADHD, attention-deficit/hyperactivity disorder; WHODAS, World Health Organization Disability Assessment Schedule 2.0, eGFR, estimated glomerular filtration rate.
Characteristics associated with hand grip strength after LASSO regression using multiply imputed data: male study participants aged ≥65 years (N=282). Because no study participants in this age/sex group had fibromyalgia, this variable was removed from the model for this group. Abbreviations: LDL, low-density lipoprotein.
Estimates (95% CI) from linear regression models using covariates selected in MI-LASSO regressions. Variance estimates were calculated using Rubin’s rules.
Among male participants (Figure 1c; Figure 1d; Table 3), Asian race was associated with approximately 3-5 kg lower HGS; Black race was associated with approximately 3 kg higher HGS among younger male participants. Categorical variables associated with ≥2 kg lower HGS included type 2 diabetes mellitus (T2DM), dry mouth, peptic ulcers, and stroke in younger male participants, while attention-deficit/hyperactivity disorder (ADHD) and irritable bowel disease were associated with ≥2 kg higher HGS. Continuous variables for which higher values were associated with lower HGS in this group included eGFR and WHODAS 2.0 score. In addition to Asian race, pneumonia was associated with ≥2 kg lower HGS in older male participants. Additionally, higher hemoglobin and LDL cholesterol levels were associated with higher HGS while higher neutrophil count was associated with lower HGS in older male participants.
Discussion
We sought to identify the most salient factors associated with HGS out of a wide range of clinical variables when stratifying by both sex and age as a means of high-throughput hypothesis generation. Our study is the first to stratify by age in order to investigate variables associated with HGS in a large, deeply phenotyped cohort, allowing comparisons across both sex and age. Our results underscore previous findings that HGS is associated with several health dimensions of interest and that these associations vary by age and sex. In addition to confirming a number of previously reported associations, our analyses also identified several novel associations with HGS that warrant further investigation in specific age and sex groups. Novel associations include eGFR in individuals aged <65, LDL cholesterol in individuals aged ≥65, psychosocial factors such as body image concerns, subjective happiness, and PANAS positive affect score in females and ADHD in males aged <65, and immune cells in males aged ≥65 and females overall.
Race was consistently associated with HGS across sex and age categories to varying degrees, findings that are consistent with published literature reporting differences in HGS across race categories [2,32,85,86]. These observed associations may be explained at least in part by differences in body composition that are often seen across differing ethnic or racial backgrounds [87,88]; however, the reasons for these observed differences are likely complex, as social factors and experiences associated with race such as health and wealth disparities, impacts of racism, and other unmeasured racialized experiences will be jointly captured by the race variable in our regression models [89].
The only other factor commonly associated with HGS across more than 2 stratified groups was immune cell count; however, the specific type of white blood cell associated with HGS differed between groups. An association between higher absolute monocyte count and lower HGS was observed in female participants aged ≥65 years, while an association between higher total lymphocyte count and lower HGS was seen in female participants aged <65 years. Among male participants aged ≥65 years, higher total neutrophil count was also associated with lower HGS, but no measure of immune cells was associated with HGS among younger male participants. Few studies have reported on associations between HGS and immune cells, although one reported an association between neutrophil dysfunction and age that was exaggerated by frailty (for which HGS is an indicator) in older adults [90]. Additionally, only one study has reported on the association between heat shock protein expression in monocytes and lymphocytes with HGS in older adults [91]. In our study, absolute monocyte count was associated with the largest estimated decrease in predicted HGS, with each 1-unit increase in absolute monocyte count being associated with a nearly 4-kg lower HGS. Immune cells other than absolute monocyte count were associated with HGS in the other groups to a lesser degree, with the estimated HGS being <1 kg lower per 1-unit increase.
In addition to sharing associations between race and HGS, female participants in our study also shared associations between bone mineral density conditions and HGS across age groups. Previous studies have reported an association between low HGS in older adults (primarily perimenopausal and postmenopausal women) and insufficient bone mineral density at sites remote from the upper extremity (e.g., spine and hip) [92-100]. In addition, HGS has been identified as a viable supplemental predictor of incident fractures when traditional bone mineral density scans (i.e., dual-energy x-ray absorptiometry) are unavailable or cost-prohibitive [77-82]. Our results, which show that lower HGS is associated with osteoporosis in older female participants and with osteopenia in female participants aged <65 years, provide additional support for these reported associations between HGS and bone mineral density. Although we did not observe associations between HGS and prevalent osteopenia or osteoporosis in male participants, others have reported this association in a large, nationally representative sample when limiting their analysis to adults aged ≥40 years [101].
Other than race and bone mineral density conditions, no variables associated with HGS were common across age groups among female participants. In female participants aged <65, several of the diagnoses associated with lower HGS are diagnoses associated with worse physical function and overall strength: breast cancer, TIA, COPD, and osteoarthritis.
Younger female participants showed a small association between higher subjective happiness scores and higher HGS; however, female participants aged ≥65 had multiple indicators of mental health associated with HGS. Most notable among these were body image concerns and GAD-7 score, both of which were associated with lower HGS. An association between body image concerns and lower HGS in older adults was also reported recently in a study using data from the Korea National Health and Nutrition Examination Survey. In this study, the authors reported that HGS was associated with accuracy of weight estimation and behaviors related to weight loss or maintenance in both male and female participants aged ≥60 years, but not among younger study participants [102].
A number of studies have investigated associations between depression and HGS; however, only 2 report associations between prevalent GAD and HGS. The first, an Irish study in adults aged ≥50 years, found an association between prevalent GAD and HGS in both female and male participants [103]. The second study reported lower HGS in female participants with GAD compared with male participants, especially with those with age of onset ≥40 years [104].
We observed no common factors associated with HGS across age categories other than race, but each age group did have different factors associated with HGS not yet reported. In male study participants aged ≥65, higher hemoglobin levels were associated with higher HGS, while a history of pneumonia was associated with lower HGS. In male participants aged <65 years, a history of ADHD or irritable bowel disease was associated with higher HGS. Although it has been previously demonstrated that ADHD in children has been associated with multiple domains of upper limb function [105], our study is the first to report an association between ADHD and HGS in adults. Similar to younger female participants, younger male participants had some diagnoses associated with lower HGS that are generally associated with worse physical function and overall strength, such as T2DM and stroke.
Symptoms unexpectedly associated with lower HGS were dry mouth (HGS approximately 3 kg lower) and peptic ulcers (approximately 5 kg lower). To our knowledge, associations between these variables and HGS have not been previously reported. However, we note that the association between HGS and dry mouth may be due at least in part to medication data not being available for inclusion in our analyses. This younger male group was also the only group overall to also have a socioeconomic status indicator associated with HGS, with income <$25,000 associated with lower HGS.
Overall, more variables were associated with HGS in participants aged <65 years regardless of sex. In this age group, higher WHODAS 2.0 score, pack-years of smoking, and eGFR were associated with lower HGS. The WHODAS 2.0, a standardized generic measure of health and disability, comprises 6 domains relating to cognition, mobility, self-care, getting along, life activities, and participation [106]. Our finding that a higher total WHODAS 2.0 score (i.e., worse disability) was associated with lower HGS is not unexpected, given previously reported associations between HGS and disability domains either directly (e.g., cognition, mobility, physical function, activity) [2-6,30,31,67,68] or indirectly (e.g., symptoms associated with depression) [24-29] measured by WHODAS 2.0 where these domains have been ascertained using other tools. However, studies linking WHODAS 2.0 disability domains (using alternative metrics) and HGS were done primarily in older adult cohorts, and WHODAS 2.0 score was not associated with HGS for those aged ≥65 years in our study. Although both female and male participants <65 demonstrated this association, the decrease in estimated HGS per unit increase (worse function) in WHODAS 2.0 was more than double for male participants.
Smoking status has likewise been associated with HGS and other measures of physical function in older adults, an association not observed in older adults in this study [107,108]. This association has also been studied in a cohort of British participants aged <65, but although the study reported an association between pack-years of smoking and other physical function measures, there was no association with HGS [109]. However, in our study this association was relatively weak, requiring a 20-pack-year smoking history to be associated with an approximate 1-kg reduction in HGS.
Higher eGFR was also associated with lower HGS in participants aged <65 years but was not associated with HGS in participants ≥65. These findings are consistent with previous studies showing that eGFR, when calculated according to the method used in this study, is not associated with HGS in older adults [110,111]. However, alternative methods for calculating eGFR have been associated with HGS in older adults in at least one other study [112]. Findings in our younger age group indicate that higher eGFR (better kidney function) is associated with lower HGS. The apparent paradox of better kidney function being associated with lower HGS may, like similar paradoxes [113,114], be due to collider bias, which can be induced when selection into the study is affected by both the variable of interest (eGFR) and the outcome (HGS), or when some other third variable affected by these two variables is adjusted for in statistical analysis [115,116]. To our knowledge, no other studies have examined the association between eGFR and HGS in participants aged <65 years.
Among study participants aged ≥65 years, higher LDL cholesterol level was associated with higher HGS, regardless of sex. Although this association was present for both older female and male participant groups, the estimated increase in HGS per unit increase in LDL was twice as high in males. Previously reported associations between LDL and HGS from older adult cohorts in other countries are consistent with this paradoxical association between higher HGS and higher levels of LDL [117,118]. Previous studies have also linked HGS with cardiovascular disease and mortality [51,53-55] and HGS with other indicators of cardiometabolic health/risk (e.g., high-density-lipoprotein cholesterol; blood pressure) [117,119]. However, LDL was the only cardiometabolic risk factor in our results associated with HGS in older adults of either sex.
We note a number of limitations to our study. First, we used cross-sectional data and methods focused on identifying factors most strongly associated with HGS as a means of high-throughput hypothesis generation rather than attempting to estimate the effect of a single specific variable on HGS that would necessitate an alternative approach [120]. As a result, some of the associations described (e.g., eGFR, LDL) may seem paradoxical if interpreted under the assumption that they reflect a causal mechanism. Second, our study sample was limited to populations in North Carolina (Durham and Kannapolis) and California (Los Angeles, Palo Alto). The sample comprised adults older than the national average and had less Hispanic representation (11.4%) than the overall U.S. population (18.5%) [121]. Because of this, the generalizability of our findings to the overall U.S. adult population may be limited.
This study identified several novel salient factors associated with HGS when stratifying by sex and age (<65 versus ≥65 years) and identified some factors that confirm previously published work. Some of these prevalent factors were common across age groups or sex groups, but several factors associated with HGS were specific to both age and sex. These results support the hypothesis that HGS may be a useful indicator of a variety of prevalent conditions, as it was associated with a range of clinical conditions, complaints, and laboratory blood measures. Novel associations identified may merit further investigation into their associations with HGS. If our novel associations are confirmed, then HGS may also be a useful indicator of these variables and further research would be warranted to estimate the direction and magnitude of any causal relationships between HGS and novel factors where biologically plausible.
Methods
Project Baseline Health Study (PBHS)
The PBHS (ClinicalTrials.gov identifier NCT03154346) is an ongoing longitudinal multicenter observational cohort study of U.S. adults. Participants contribute demographic, clinical, imaging, and laboratory data at annual visits. The PBHS is funded by Verily Life Sciences and managed in collaboration with Stanford University, Duke University, and the California Health and Longevity Institute. Written informed consent is obtained from all participants enrolled in the PBHS and the study is approved by both a central institutional review board (IRB) (Western IRB) and individual IRBs at each of the participating institutions. All study procedures and study data collection are conducted in accordance with the principles described in the Declaration of Helsinki and with relevant local, state, national, and international standards. Detailed descriptions of study procedures and methods, including exclusion and inclusion criteria and institutional review board approval and enrollment procedures, have been published [83,84].
In this study, we examined cross-sectional data collected at study participants’ baseline visit or collected remotely at that time via survey or connected device. Participants were enrolled through sites affiliated with Stanford University (Palo Alto, CA), Duke University (Durham, NC and Kannapolis, NC), and California Health and Longevity Institute (CHLI; Los Angeles, CA).
Hand grip strength
HGS was recommended to be measured using the Jamar Plus+ Hand Dynamometer (Patterson Medical). Participants were asked to perform 3 trials measuring peak grip force (kg) with a 10-20 second break between each trial for dominant and non-dominant hands. If the difference between any 2 measures on a single hand was greater than 2.99 kg, a fourth trial was done after a 1-minute resting period. For the purposes of this analysis, HGS was defined as the mean of the dominant hand from the 3-4 trials.
Other variables
A detailed description of data collected from BHS participants has been previously described [83]. We present a summary of the ascertainment and definition of the 175 variables eligible for entry into each model in the Appendix.
Statistical analysis
Demographic and clinical characteristics including medical conditions, symptoms, patient-reported outcomes, and laboratory measures were described among participants who completed HGS assessments at their baseline visits. Male and female participants were described separately and they were classified into one of 3 cohort-based HGS percentile groups: lowest 25%, middle 50%, and highest 25%.
The Cochran-Armitage test for trend was used to test for associations between HGS and categorical variables of interest, the Spearman rank correlation test was used for continuous variables. Data collected within 200 days of participants’ baseline visits were considered nonmissing. Multiple imputation by chained equations (MICE) methods were used to address missing data [122].
LASSO regression
Least absolute shrinkage and selection operator procedures addressing multiply imputed data by using group methods [123] (MI-LASSO) were employed to identify variables potentially associated with HGS, which was treated as a continuous outcome. Analyses were performed separately for male and female participants, further stratified by age (<65 years vs. ≥ 65 years), resulting in 4 LASSO regression models. All variables were standardized to allow for meaningful comparison of coefficients. For each age-sex category, shrinkage of coefficients was controlled by a tuning parameter determined by the model that minimized the Bayesian Information Criterion.
Linear regressions using variables selected from the LASSO were performed for each of the 4 age-sex categories to allow for more interpretable coefficient estimates for each variable identified by MI-LASSO. Regression estimates from each imputed dataset were pooled into a single value whose variance was then calculated using Rubin’s rules [124,125].
Analyses were completed using R v3.6.3 [126]. Data were imputed and linear regressions were performed using the MICE package v3.13.0 [122]. LASSO regressions were carried out using the MI.LASSO function [123]. Missing data were imputed using observational data over a series of 5 instances, with 5 iterations per imputation. Tables were created using Python v3.7.10; figures were created with ggplot2 v3.3.0 [127].
Author contributions
Kenneth A. Taylor – Conceptualization, Methodology, Writing – Original draft preparation, Project administration
Megan K. Carroll - Conceptualization, Methodology, Formal analysis, Visualization, Writing – Original draft preparation
Sarah Short – Methodology, Data curation, Writing – Review and Editing Adam P. Goode – Writing – Review and Editing
Declaration of competing interests
KAT and APG have no competing interests to declare. MKC and SS are employees of Verily Life Sciences.
Data availability
The de-identified Project Baseline Health Study (PBHS) data corresponding to this study are available upon request for the purpose of examining its reproducibility. Interested investigators should direct requests to sarahshort{at}verily.com. Requests are subject to approval by PBHS governance.
Funding
The Baseline Health Study and this analysis were funded by Verily Life Sciences, San Francisco, CA. This analysis was funded by Verily Life Sciences (San Francisco, CA) in partnership with Stanford University and Duke University. The employees from funding source contributed to the data analyses, interpretation, editing of the manuscript and are coauthors. The final decision to submit the manuscript was made by the academic authors.
Acknowledgments
Baseline Health Study Team: American Society of Clinical Oncology, Alexandria, VA, USA: Richard L. Schilsky. Duke University, School of Medicine, Durham, NC, USA: Jennifer Allen, MaryAnn Anderson, Kevin Anstrom, Lucus Araujo, Kristine Arges, Kaveh Ardalan, Bridget Baldwin, Suresh Balu, Mustafa R. Bashir, Manju Bhapkar, Robert Bigelow, Tanya Black, Rosalia Blanco, Gerald Bloomfield, Durga Borkar, Leah Bouk, Ebony Boulware, Nikki Brugnoni, Erin Campbell, Paul Campbell, Larry Carin, Tammy Jo Cassella, Tina Cates, Ranee Chatterjee Montgomery, Victoria Christian, John Choong, Michael Cohen-Wolkowiez, Elizabeth Cook, Scott Cousins, Ashley Crawford, Nisha Datta, Melissa Daubert, James Davis, Jillian Dirkes, Isabelle Doan, Marie Dockery, P. Murali Doraiswamy, Pamela S. Douglas, Shelly Duckworth, Ashley Dunham, Gary Dunn, Ryan Ebersohl, Julie Eckstrand, Vivienne Fang, April Flora, Emily Ford, Lucia Foster, Elizabeth Fraulo, John French, Geoffrey S. Ginsburg, Cindy Green, Latoya Greene, Jeffrey Guptill, Donna Hamel, Jennifer Hamill, Chris Harrington, Rob Harrison, Lauren Hedges, Brooke Heidenfelder, Adrian F. Hernandez, Cindy Heydary, Tim Hicks, Lina Hight, Deborah Hopkins, Erich S. Huang, Grace Huh, Jillian Hurst, Kelly Inman, Gemini Janas, Glenn Jaffee, Janace Johnson, Tiffanie Keaton, Michel Khouri, Daniel King, Jennifer Korzekwinski, Lynne H. Koweek, Anthony Kuo, Lydia Kwee, Dawn Landis, Rachele Lipsky, Desiree Lopez, Carolyn Lowry, Kelly Marcom, Keith Marsolo, Paige McAdams, Shannon McCall, Robert McGarrah, John McGugan, Dani Mee, Sabrena Mervin-Blake, Prithu Mettu, Mathias Meyer, Justin Meyers, Calire N. Miller, Rebecca Moen, Lawrence H. Muhlbaier, Michael Murphy, Ben Neely, L. Kristin Newby, Jayne Nicoldson, Hoang Nguyen, Maggie Nguyen, Lori O’Brien, Sumru Onal, Jeremey O’Quinn, David Page, Neha J. Pagidipati, Kishan Parikh, Sarah R. Palmer, Bray Patrick-Lake, Brenda Pattison, Michael Pencina, Eric D. Peterson, Jon Piccini, Terry Poole, Tom Povsic, Alicia Provencher, Dawn Rabineau, Annette Rich, Susan Rimmer, Fides Schwartz, Angela Serafin, Nishant Shah, Svati Shah, Kelly Shields, Steven Shipes, Peter Shrader, Jon Stiber, Lynn Sutton, Geeta Swamy, Betsy Thomas, Sandra Torres, Debara Tucci, Anthony Twisdale, Susan A. Whitney, Robin Williamson, Lauren Wilverding, Charlene A. Wong, Lisa Wruck. Ellen Young Gemini Group, USA: Jane Perlmutter. Health Collaboratory and Cancer 101, New York, NY, USA: Sarah Krug. Rare Dots, Inc., USA: S. Whitney Bowman-Zatzkin. Society of Participatory Medicine, USA: Sarah Krug. Stanford University, School of Medicine, Stanford, CA, USA: Themistocles Assimes, Vikram Bajaj, Maxwell Cheong, Millie Das, Manisha Desai, Alice C. Fan, Dominik Fleischmann, Sanjiv S. Gambhir, Garry Gold, Francois Haddad, David Hong, Curtis Langlotz, Yaping J. Liao, Rong Lu, Kenneth W. Mahaffey, David Maron, Rebecca McCue, Rajan Munshi, Fatima Rodriguez, Sumana Shashidhar, George Sledge, Susie Spielman, Ryan Spitler, Sue Swope, Donna Williams, Julio C. Nunes. University of Florida, College of Medicine, Gainesville, FL, USA: Carl J Pepine. University of Missouri, Children’s Mercy Hospital, Kansas City, MO, USA: John D Lantos. University of Texas, Dell Medical School, Austin, TX, USA: Michael Pignone. University of Washington, Department of Biostatistics, Seattle, WA, USA: Patrick Heagerty. Vanderbilt University, School of Medicine, Nashville, TN, USA: Laura Beskow, Gordon Bernard. Verily Inc., South San Francisco, CA, USA: Kelley Abad, Giulia Angi, Robert M. Califf, Lawrence Deang, Joy Huynh, Manway Liu, Cherry Mao, Michael Magdaleno, William J. Marks, Jr., Jessica Mega, David Miller, Nicole Ong, Darshita Patel, Vanessa Ridaura, Scarlet Shore, Sarah Short, Michelle Tran, Veronica Vu, Celeste Wong. Harvard University, School of Medicine, Boston, MA, USA: Robert C. Green. Google Inc., Mountain View, CA, USA: John Hernandez. California Health and Longevity Institute, Westlake Village, CA, USA: Jolene Benge, Gislia Negrete, Gelsey Sierra, Terry Schaack
References
- 1.↵
- 2.↵
- 3.
- 4.
- 5.
- 6.↵
- 7.↵
- 8.↵
- 9.
- 10.
- 11.↵
- 12.↵
- 13.
- 14.
- 15.↵
- 16.↵
- 17.
- 18.
- 19.↵
- 20.↵
- 21.
- 22.
- 23.↵
- 24.↵
- 25.
- 26.
- 27.
- 28.
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- 33.
- 34.
- 35.↵
- 36.
- 37.
- 38.
- 39.
- 40.
- 41.↵
- 42.↵
- 43.
- 44.
- 45.
- 46.
- 47.↵
- 48.↵
- 49.↵
- 50.↵
- 51.↵
- 52.↵
- 53.↵
- 54.↵
- 55.↵
- 56.↵
- 57.
- 58.
- 59.
- 60.
- 61.
- 62.
- 63.
- 64.
- 65.
- 66.↵
- 67.↵
- 68.↵
- 69.
- 70.
- 71.
- 72.
- 73.
- 74.↵
- 75.↵
- 76.
- 77.↵
- 78.
- 79.
- 80.
- 81.
- 82.↵
- 83.↵
- 84.↵
- 85.↵
- 86.↵
- 87.↵
- 88.↵
- 89.↵
- 90.↵
- 91.↵
- 92.↵
- 93.
- 94.
- 95.
- 96.
- 97.
- 98.
- 99.
- 100.↵
- 101.↵
- 102.↵
- 103.↵
- 104.↵
- 105.↵
- 106.↵
- 107.↵
- 108.↵
- 109.↵
- 110.↵
- 111.↵
- 112.↵
- 113.↵
- 114.↵
- 115.↵
- 116.↵
- 117.↵
- 118.↵
- 119.↵
- 120.↵
- 121.↵
- 122.↵
- 123.↵
- 124.↵
- 125.↵
- 126.↵
- 127.↵
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos